Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -14.43M | -2956.35% | $ 488K |
3/31/2025 | $ -14.15M | -2645.61% | $ 535K |
12/31/2024 | $ -15.84M | -2720.96% | $ 582K |
9/30/2024 | $ -16.95M | -2834.78% | $ 598K |
6/30/2024 | $ -16.49M | -10180.86% | $ 162K |
3/31/2024 | $ -18.11M | -15744.35% | $ 115K |
12/31/2023 | $ -20.41M | -30011.76% | $ 68K |
9/30/2023 | $ -21.18M | -41533.33% | $ 51K |
6/30/2023 | $ -21.47M | 0% | $ 0 |
3/31/2023 | $ -21.59M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ERNEXA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -2.3M ] / Revenues [ $ 9.79M ]
(=) OCF % [ -23.46% ]
Minimum
Sep 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |